ENFLONSIA

What is this medication? Trelegy Ellipta is a prescription inhalation medication that contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. It is primarily used for the long-term, once-daily maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease, commonly known as COPD. This condition includes chronic bronchitis and emphysema. The medication is designed to help patients manage their symptoms by improving overall lung function and making breathing easier throughout the day. The combination of these three medicines works by reducing inflammation in the lungs and relaxing the muscles in the airways to keep them open. Beyond daily maintenance, Trelegy Ellipta is also used to reduce the frequency of COPD exacerbations or flare-ups in patients with a history of such events. It is important to note that this medication is not a rescue inhaler and should not be used to treat sudden or acute breathing problems. Users should follow the guidance of their healthcare provider to ensure the medication is used safely and effectively.